Ellen Marmur, MD
MOHS-Micrographic Surgery · New York, NYNPI 1134114655
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.7%), grants and speaking fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Galderma Laboratories, L.p. at 34.3% of the total. Reporting peaked in 2020 at $43,223 and has fallen 59.4% since, to $17,535 in 2025. Among mohs-micrographic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $661.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$64K
- Musculoskeletal Transplant Foundation Inc.$40K
- Solta Medical, A Division Of Bausch Health US, LLC$34K
- Merz North America, Inc.$29K
- Revance Therapeutics, Inc.$11K
- AbbVie$6K
- plus $2K from 22 others
What the payments were for
- Consulting fees$103,53856%
- Speaking & faculty fees$16,8759%
- Grants$42,50023%
- Travel & lodging$7430%
- Food & beverage$16,3649%
- Education$800%
- Gifts$5,7773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 43 | $63,738 |
| Musculoskeletal Transplant Foundation Inc. | 16 | $39,825 |
| Solta Medical, A Division Of Bausch Health US, LLC | 5 | $34,092 |
| Merz North America, Inc. | 62 | $29,194 |
| Revance Therapeutics, Inc. | 13 | $10,798 |
| AbbVie(2 entities) | 53 | $6,189 |
| Dermavant Sciences, Inc. | 12 | $210 |
| Johnson & Johnson | 9 | $205 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $204 |
| VYNE Pharmaceuticals Inc. | 8 | $171 |
| Incyte Corporation | 2 | $153 |
| LEO Pharma Inc. | 6 | $148 |
| E.r. Squibb & Sons, L.L.C. | 6 | $143 |
| Pfizer | 5 | $125 |
| Sanofi | 4 | $119 |
| Mayne Pharma Commercial LLC | 3 | $85 |
| Botanix SB Inc | 3 | $79 |
| Lilly USA, LLC | 2 | $59 |
| Journey Medical Corporation | 2 | $48 |
| Sun Pharmaceutical Industries Inc. | 2 | $45 |
| Aclaris Therapeutics, Inc. | 2 | $44 |
| Genentech USA, Inc. | 2 | $42 |
| Encore Dermatology Inc. | 2 | $37 |
| EPI Health, LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $26 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$13,436
- BOTOX COSMETIC$5,418
- DAXXIFY$3,393
- ASCLERA$1,186
- DYSPORT$135
- OPZELURA$125
- AKLIEF$124
- EPIDUO FORTE$124
- ORACEA$124
How this compares
$185,877 in reported general payments places this provider in the 95th percentile of 75 mohs-micrographic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 119 | $4,964 |
| Fluorouracil | 46 | $2,580 |
| Ciclopirox | 23 | $1,910 |
| Metronidazole | 12 | $1,400 |
| Triamcinolone Acetonide | 125 | $1,357 |
| Mupirocin | 129 | $1,099 |
| Imiquimod | 25 | $682 |
| ValacyclovirValacyclovir Hcl | 22 | $651 |
| Minoxidil | 74 | $541 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 12 | $358 |
| Fluocinolone Acetonide | 11 | $344 |
| Doxycycline Hyclate | 23 | $335 |
| Ketoconazole | 22 | $329 |
| Clindamycin Phosphate | 12 | $254 |
| Nystatin | 11 | $209 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in New York
- Michael TassavorNew York$55K
- Jane YooNew York$42K
- Hamza BhattiNew York$40K
- Desiree RatnerNew York$32K
- Omar Torres LozadaNew York$13K
- Ronald SheltonNew York$10K
- Sarah YagermanNew York$8K
- John CarucciNew York$6K
- Faramarz SamieNew York$5K
- Hooman KhorasaniNew York$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.